History
  • No items yet
midpage
Charolette Payne v. Novartis Pharm. Corp.
767 F.3d 526
6th Cir.
2014
Read the full case

Background

  • Charolette Payne received Novartis’s bisphosphonate drugs Aredia (1999) and Zometa (2001) for metastatic breast cancer; she later developed osteonecrosis of the jaw (ONJ) and underwent partial jaw resection in 2009.
  • Payne sued Novartis for failure to warn that Aredia/Zometa could cause ONJ; consolidated in MDL and remanded to district court, which granted summary judgment for Novartis on proximate-cause grounds.
  • Dr. Darrell Johnson (Payne’s oncologist) testified he was unaware of the ONJ risk when prescribing but now warns patients of ONJ and recommends pre-treatment dental exams.
  • Payne submitted an affidavit stating she would not have taken the drugs if she had been warned of ONJ.
  • The district court characterized Payne’s affidavit as speculative and concluded Novartis’s failure to warn was not a proximate cause under Tennessee’s learned intermediary doctrine.
  • The Sixth Circuit reversed, holding that Payne’s and her doctor’s testimony create genuine issues of fact for a jury on causation.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether Novartis’s failure to warn was a proximate cause of Payne’s ONJ Novant(is) would have warned Dr. Johnson; Dr. Johnson would have warned Payne; Payne would have refused the drugs and avoided ONJ District court: Payne’s affidavit that she would have refused is speculative; no causal link proven Reversed — jury question: combined affidavit and doctor testimony can establish causal link under Tennessee law
Proper application of the learned intermediary doctrine in causation analysis Plaintiff: doctrine does not bar patient testimony that she would have refused treatment upon adequate warning Novartis: doctrine shifts causation inquiry to physician actions; plaintiff’s counterfactual choice is insufficient Court: Tennessee allows patient testimony on what she would have done; doctrine does not foreclose submission to jury

Key Cases Cited

  • Haynes v. Hamilton Cnty., 883 S.W.2d 606 (Tenn. 1994) (causation is ordinarily a jury question unless facts make outcome clear)
  • Hale v. Ostrow, 166 S.W.3d 713 (Tenn. 2005) (plaintiff must show defendant’s omission was a substantial factor in causing harm)
  • Pittman v. Upjohn Co., 890 S.W.2d 425 (Tenn. 1994) (drug manufacturers’ duty to warn; context for learned intermediary doctrine)
  • Ashe v. Radiation Oncology Assocs., 9 S.W.3d 119 (Tenn. 1999) (patient’s testimony about what she would have done upon full disclosure is admissible on causation)
  • Anderson v. Liberty Lobby, Inc., 477 U.S. 242 (U.S. 1986) (summary judgment standard; credibility and inference issues for jury)
  • Celotex Corp. v. Catrett, 477 U.S. 317 (U.S. 1986) (movant’s burden on summary judgment)
Read the full case

Case Details

Case Name: Charolette Payne v. Novartis Pharm. Corp.
Court Name: Court of Appeals for the Sixth Circuit
Date Published: Aug 18, 2014
Citation: 767 F.3d 526
Docket Number: 13-6266
Court Abbreviation: 6th Cir.